Tango Therapeutics Sub, Inc

Contributing Author

Recent Articles by Tango Therapeutics Sub, Inc

12 hours	Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights TNGX +36.28% GlobeNewswire
Feb-18	Tango Therapeutics to Report Fourth Quarter 2025 Financial Results and Participate in Three Upcoming Investor Conferences TNGX GlobeNewswire
Feb-03	Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 TNGX +5.11% GlobeNewswire
Jan-08	Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor TNGX -6.23% GlobeNewswire
Jan-05	Tango Therapeutics Appoints Sung Lee to Board of Directors TNGX GlobeNewswire
Dec-17	Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference TNGX GlobeNewswire
Nov-26	Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference TNGX GlobeNewswire
Nov-12	Tango Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference TNGX -8.47% GlobeNewswire
Nov-04	Tango Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights TNGX GlobeNewswire
Oct-29	Tango Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 TNGX GlobeNewswire
Oct-23	Tango Therapeutics Announces $225 Million Financing TNGX -13.05% GlobeNewswire
Oct-23	Tango Therapeutics Reports Positive Data from Ongoing Phase 1/2 Study with Vopimetostat (TNG462) in Patients with MTAP-deleted Cancers TNGX -13.05% GlobeNewswire